Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD4 | P01730 | 2/20 | 0.60 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.57 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5680202 | 0.87 | ALDH1A1 (0.71) | CD4SORT1ALDH1A1POLBPKM | |
| SCHEMBL13925192 | 0.83 | CD4 (0.81) | CD4SORT1ALDH1A1POLBPKM | |
| SCHEMBL9709591 | 0.81 | ALDH1A1 (0.62) | CD4SORT1ALDH1A1POLBPKM | |
| SCHEMBL21681941 | 0.81 | ALDH1A1 (0.74) | ALDH1A1POLBPKMHTTLMNA | |
| SCHEMBL3156886 | 0.81 | KDM4E (0.73) | ALDH1A1POLBLMNASMN1; SMN2 | |
| SCHEMBL13925209 | 0.80 | CD4 (0.80) | CD4SORT1ALDH1A1POLBPKM | |
| SCHEMBL17961883 | 0.80 | KDM4E (0.70) | ALDH1A1PKMLMNASMN1; SMN2 | |
| SCHEMBL1258731 | 0.79 | CD4 (0.74) | CD4SORT1ALDH1A1POLBPKM | |
| SCHEMBL2206628 | 0.78 | KDM4E (0.73) | ALDH1A1POLBLMNASMN1; SMN2 | |
| SCHEMBL7485956 | 0.78 | ALDH1A1 (0.79) | ALDH1A1HTTLMNASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7557205-B2 | For improving contrast of X-ray, ultrasound, radionuclide and magnetic resonance images | THE HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2009-07-07 | — | — | US | disclosed |
| US-20060069249-A1 | For improving contrast of X-ray, ultrasound, radionuclide and magnetic resonance images | HONG KONG POLYTECHNIC UNIVERSITY (CN) | 2006-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060069249-A1 | For improving contrast of X-ray, ultrasound, radionuclide and magnetic resonance images | SON, SPIN3, SHROOM3 | CD4 4084/4885SORT1 3788/4885ALDH1A1 4526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.